Identifying and Validating Clusters of Menopausal Symptoms Across Reproductive Stages

Abstract Biological changes during the menopausal transition produce symptoms across multiple domains, yet clinical profiles remain poorly understood, hindering screening and targeted care. This study aimed to identify and validate menopausal symptom clusters and examine their variation across reproductive stages. Women aged 35–60 years (n = 741) enrolled in the Human Papillomavirus in Perimenopause study were followed for two years and completed four semiannual follow-up visits assessing genitourinary, vasomotor, other physical, and mood-related menopausal symptoms. Latent class models were fit using all available data (2,360 person-visits) to identify symptom clusters. Models with two to six classes were compared via fit statistics, posterior probabilities, item-response probabilities, and interpretability. Participants were assigned to the symptom cluster for which they had the highest posterior probability. Four classes emerged: the multi-domain cluster (21.0%) had high probabilities for all symptoms; the asymptomatic cluster (30.6%) had uniformly low symptom burden; the mood/somatic cluster (27.0%) showed elevated psychological and non-specific physical symptoms; and the genitourinary/vasomotor cluster (21.4%) was marked by vaginal dryness, decreased sexual interest, and vasomotor symptoms. Age and the proportion of postmenopausal women were significantly higher in the multi-domain (49.8 years; 47.1%) and genitourinary/vasomotor (50.8 years; 46.3%) clusters than in the mood/somatic and asymptomatic clusters. These participants were also more likely to exhibit clinical signs of genitourinary syndrome of menopause, have lower current hormone use and estradiol levels, and were less likely to have Lactobacillus-dominant vaginal microbial communities. Menopausal symptoms cluster differently across reproductive stages, which may inform screening and targeted care.

Authors

Institutions

Publication Details

Journal
Innovation in Aging
Published
2025-12-01
DOI
https://doi.org/10.1093/geroni/igaf122.3959
Primary Topic
Menopause: Health Impacts and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Identifying and Validating Clusters of Menopausal Symptoms Across Reproductive Stages

M. Shardell, Alan M. Rathbun, Rebecca M. Brotman, Sarah E. Brown et al.
Innovation in Aging
Menopause: Health Impacts and Treatments
article

Identifying and Validating Clusters of Menopausal Symptoms Across Reproductive Stages

M. Shardell, Alan M. Rathbun, Rebecca M. Brotman, Sarah E. Brown, Jacques Ravel, Joanna Borgogna
article en

Abstract

Abstract Biological changes during the menopausal transition produce symptoms across multiple domains, yet clinical profiles remain poorly understood, hindering screening and targeted care. This study aimed to identify and validate menopausal symptom clusters and examine their variation across reproductive stages. Women aged 35–60 years (n = 741) enrolled in the Human Papillomavirus in Perimenopause study were followed for two years and completed four semiannual follow-up visits assessing genitourinary, vasomotor, other physical, and mood-related menopausal symptoms. Latent class models were fit using all available data (2,360 person-visits) to identify symptom clusters. Models with two to six classes were compared via fit statistics, posterior probabilities, item-response probabilities, and interpretability. Participants were assigned to the symptom cluster for which they had the highest posterior probability. Four classes emerged: the multi-domain cluster (21.0%) had high probabilities for all symptoms; the asymptomatic cluster (30.6%) had uniformly low symptom burden; the mood/somatic cluster (27.0%) showed elevated psychological and non-specific physical symptoms; and the genitourinary/vasomotor cluster (21.4%) was marked by vaginal dryness, decreased sexual interest, and vasomotor symptoms. Age and the proportion of postmenopausal women were significantly higher in the multi-domain (49.8 years; 47.1%) and genitourinary/vasomotor (50.8 years; 46.3%) clusters than in the mood/somatic and asymptomatic clusters. These participants were also more likely to exhibit clinical signs of genitourinary syndrome of menopause, have lower current hormone use and estradiol levels, and were less likely to have Lactobacillus-dominant vaginal microbial communities. Menopausal symptoms cluster differently across reproductive stages, which may inform screening and targeted care.

Innovation in AgingVol. 9(Supplement_2)
University of Maryland, Baltimore (US), McLaughlin Research Institute (US)
Gender equality
Openalex Percentile: Top 28%
Menopause: Health Impacts and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.